These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Susca M; Grassi A; Zauli D; Volta U; Lenzi M; Marchesini G; Bianchi FB; Ballardini G Dig Liver Dis; 2001 Dec; 33(9):768-77. PubMed ID: 11838612 [TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis: an overview. Shifflet A; Wu GY J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602 [TBL] [Abstract][Full Text] [Related]
9. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Lonardo A Dig Dis; 1999; 17(2):80-9. PubMed ID: 10545713 [TBL] [Abstract][Full Text] [Related]
10. Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Mato JM; Lu SC Hepatology; 2011 Oct; 54(4):1115-7. PubMed ID: 21898494 [No Abstract] [Full Text] [Related]
13. Epidemiology and natural history of NAFLD and NASH. Ong JP; Younossi ZM Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Bookman ID; Pham J; Guindi M; Heathcote EJ Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001 [TBL] [Abstract][Full Text] [Related]